6-ethyl-2-oxo-1,2-dihydropyridine-4-carboxylic acid - CAS 54881-17-3
Catalog: |
BB055191 |
Product Name: |
6-ethyl-2-oxo-1,2-dihydropyridine-4-carboxylic acid |
CAS: |
54881-17-3 |
Synonyms: |
6-ethyl-2-oxo-1,2-dihydropyridine-4-carboxylic acid; 2-ethyl-6-oxo-1H-pyridine-4-carboxylic acid; 2-ethyl-6-hydroxypyridine-4-carboxylic acid; 6-ethyl-2-oxo-1,2-dihydro-pyridine-4-carboxylic acid; 6-ethyl-2-oxo-1,2-dihydro-4-pyridinecarboxylic acid; 2-Ethyldihydro-6-oxoisonicotinic acid |
IUPAC Name: | 2-ethyl-6-oxo-1H-pyridine-4-carboxylic acid |
Description: | 6-ethyl-2-oxo-1,2-dihydropyridine-4-carboxylic acid (cas# 54881-17-3) is a useful research chemical. |
Molecular Weight: | 167.16 |
Molecular Formula: | C8H9NO3 |
Canonical SMILES: | CCC1=CC(=CC(=O)N1)C(=O)O |
InChI: | InChI=1S/C8H9NO3/c1-2-6-3-5(8(11)12)4-7(10)9-6/h3-4H,2H2,1H3,(H,9,10)(H,11,12) |
InChI Key: | QTGMQKBCDNYHSK-UHFFFAOYSA-N |
Melting Point: | >286°C (dec.) |
Solubility: | DMSO (Slightly), Methanol (Slightly, Heated, Sonicated) |
Appearance: | Pale Yellow to Pale Beige Solid |
Storage: | -20°C, Inert atmosphere |
GHS Hazard Statement: | H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation] |
Precautionary Statement: | P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
CN-105492438-A | Sulfoximine substituted 5-fluoro-n-(pyridin-2-yl)pyridin-2-amine derivatives and their use as CDK9 kinase inhibitors | 20130704 |
CN-105492438-B | The fluoro- N- of 5- (pyridine -2- bases) pyridine -2- amine derivatives of sulphur imines substitution as well as the purposes of CDK9 kinase inhibitors | 20130704 |
EP-3016945-A1 | Sulfoximine substituted 5-fluoro-n-(pyridin-2-yl)pyridin-2-amine derivatives and their use as cdk9 kinase inhibitors | 20130704 |
EP-3016945-B1 | Sulfoximine substituted 5-fluoro-n-(pyridin-2-yl)pyridin-2-amine derivatives and their use as cdk9 kinase inhibitors | 20130704 |
JP-2016523282-A | Sulfoximine substituted 5-fluoro-N- (pyridin-2-yl) pyridin-2-amine derivatives and their use as CDK9 kinase inhibitors | 20130704 |
JP-6371385-B2 | Sulfoximine substituted 5-fluoro-N- (pyridin-2-yl) pyridin-2-amine derivatives and their use as CDK9 kinase inhibitors | 20130704 |
US-2016143893-A1 | Sulfoximine substituted 5-fluoro-n-(pyridin-2-yl)pyridin-2-amine derivatives and their use as cdk9 kinase inhibitors | 20130704 |
US-9770445-B2 | Sulfoximine substituted 5-fluoro-N-(pyridin-2-yl)pyridin-2-amine derivatives and their use as CDK9 kinase inhibitors | 20130704 |
WO-2015001021-A1 | Sulfoximine substituted 5-fluoro-n-(pyridin-2-yl)pyridin-2-amine derivatives and their use as cdk9 kinase inhibitors | 20130704 |
AU-2006332124-A1 | 3 , 5-substitgammaued piperidine compounds as renin inhibitors | 20051230 |
PMID | Publication Date | Title | Journal |
1107 | 19750501 | [Modification of pancreatic ribonuclease activity in complexes with polyanions] | Biokhimiia (Moscow, Russia) |
Complexity: | 289 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 167.058243149 |
Formal Charge: | 0 |
Heavy Atom Count: | 12 |
Hydrogen Bond Acceptor Count: | 3 |
Hydrogen Bond Donor Count: | 2 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 167.058243149 |
Rotatable Bond Count: | 2 |
Topological Polar Surface Area: | 66.4Ų |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 0.3 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Other Building Blocks
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS